Dr. Sean Grimm from Northwestern University, Feinberg School of Medicine on MGMT as a Predictive Marker in Brain Cancer
Sean Grimm, MD
Advertisement
Articles by Sean Grimm, MD
Dr. Grimm from Northwestern University, Feinberg School of Medicine Discusses Brain Cancer Risk Factors
Advertisement
Latest Updated Articles
Dr. Grimm Discusses Primary Brain Cancer Risk FactorsPublished: October 31st 2011 | Updated:
Dr. Grimm on the Brain Cancer Predictive Marker MGMTPublished: November 4th 2011 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
5